Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer.
about
Metabolic syndrome is associated with increased breast cancer risk: a systematic review with meta-analysisBreast cancer survival among young women: a review of the role of modifiable lifestyle factorsCtBP1 associates metabolic syndrome and breast carcinogenesis targeting multiple miRNAsMetabolic syndrome and breast cancer risk: a case-cohort study nested in a multicentre italian cohortThe LKB1-AMPK pathway: metabolism and growth control in tumour suppressionPrognostic factors in early breast cancer associated with body mass index, physical functioning, physical activity, and comorbidity: data from a nationwide Danish cohort.Whole-body vibration slows the acquisition of fat in mature female ratsLeptin/HER2 crosstalk in breast cancer: in vitro study and preliminary in vivo analysisNatural killer cells in obesity: impaired function and increased susceptibility to the effects of cigarette smoke.Association of obesity and circulating adipose stromal cells among breast cancer survivors.Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: a nested case-control studyInsulin-sensitizing therapy attenuates type 2 diabetes-mediated mammary tumor progression.Plasma homocysteine and cysteine and risk of breast cancer in women.Mammalian target of rapamycin inhibition abrogates insulin-mediated mammary tumor progression in type 2 diabetes.Metabolic syndrome and outcome after breast reconstructionDesign and development of a peptide-based adiponectin receptor agonist for cancer treatment.HER2 induces expression of leptin in human breast epithelial cells.Hypertension, antihypertensive medication use, and breast cancer risk in the California Teachers Study cohort.Insulin-mediated acceleration of breast cancer development and progression in a nonobese model of type 2 diabetesAdiponectin pathway polymorphisms and risk of breast cancer in African Americans and Hispanics in the Women's Health Initiative.Conjugated linoleic acid reduces body weight gain in ovariectomized female C57BL/6J mice.Metabolic syndrome and mammographic density in Mexican womenObesity, adipocytokines and cancerDiabetogenic glucose and insulin concentrations modulate transcriptome and protein levels involved in tumour cell migration, adhesion and proliferation.Reciprocal interactions between breast tumor and its adipose microenvironment based on a 3D adipose equivalent modelVariants of the adiponectin and adiponectin receptor 1 genes and breast cancer risk.Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk.Adipose tissue-derived progenitor cells and cancerAdiponectin gene and risk of colorectal cancer.Metabolic syndrome and cancerImplications of Type1/2 Diabetes Mellitus in Breast Cancer Development: A General Female Population-based Cohort StudyEstrogen exposure, obesity and thyroid disease in women with severe pulmonary hypertension.Common genetic variation in adiponectin, leptin, and leptin receptor and association with breast cancer subtypes.The association of diabetes with breast cancer incidence and mortality in the Long Island Breast Cancer Study Project.Exogenous estrogen protects mice from the consequences of obesity and alcohol.Honokiol abrogates leptin-induced tumor progression by inhibiting Wnt1-MTA1-β-catenin signaling axis in a microRNA-34a dependent manner.Estrogen deprivation and excess energy supply accelerate 7,12-dimethylbenz(a)anthracene-induced mammary tumor growth in C3H/HeN mice.Obesity and risk of recurrence or death after adjuvant endocrine therapy with letrozole or tamoxifen in the breast international group 1-98 trial.Green Tea Extract and Catechol-O-Methyltransferase Genotype Modify Fasting Serum Insulin and Plasma Adiponectin Concentrations in a Randomized Controlled Trial of Overweight and Obese Postmenopausal Women.Honokiol activates LKB1-miR-34a axis and antagonizes the oncogenic actions of leptin in breast cancer.
P2860
Q23920590-8993C1AA-1615-4E8A-BB26-6843F20C26B9Q26766205-A6416617-126D-48ED-A009-E911FCF66A0DQ28384566-65DB9513-FA76-493A-9632-0E96FF03ECE9Q28395376-46378A18-15DB-4515-96A0-3077EEDEEC5AQ29617506-DBD52BD2-3CD9-46C2-85A8-20A7129FD15CQ31154302-B2844263-E47A-4CDF-A8A5-A93476C33647Q33355748-609C6AE9-7A33-471A-97A5-BC3A33BBD203Q33378824-5EC19176-58B0-46CC-8677-10F1D449DE61Q33526964-FBEA0404-611A-4990-B406-4518E127D952Q33591042-D71C6380-745D-4651-BF02-3C09EF5529F6Q33643001-F5AE4C28-5F43-4D33-B807-C7FF5D3083A4Q33688576-F8E66E15-7830-4BCA-A2F1-C8C24A15AD9DQ33733182-6042E178-769D-4E40-8D61-567CF4BD723FQ33849666-712F1C97-A501-446B-B64C-DBAB55AFE424Q33973160-7BC0FF47-6A03-49B8-A4CC-85E4D6176C67Q34040946-90A3C19A-46DD-4588-AC75-C32B802AB69FQ34049205-63D55AFB-182D-432B-8E85-930C28A36734Q34134850-682EA47F-F764-4480-AE14-E6F5F7FE105EQ34157626-16E517C2-E963-4A98-8E35-F7BADA7C55FBQ34341656-FEBD6CF0-A759-42C6-9DF3-360B0A59AFD3Q34398819-B1762335-9AC3-4A61-AA11-480DF6E77194Q34488889-87A0AAD3-FC26-4EAD-9847-D172D6A08C39Q34497726-33530086-DFC5-426B-AEF8-1FEDA958A1D3Q34543788-B24CF955-EF6E-4B7E-B5BC-4B50EE4F5D5DQ34764406-EE2A46B5-452E-4450-A93C-223B744A0B17Q34775338-988FDC24-95A0-4CD2-A2EA-CE04637B439EQ34841443-5098950D-7E70-47B7-AC36-9818FEEF328FQ34992296-66214963-4F02-4CAC-A02B-3D056CDC9A8CQ35208048-34ED9F04-58DB-416B-B5B2-A6FB5D4E1D69Q35319301-DED5C925-E9D4-4D8E-9368-49C75A1E0D55Q35856841-9D06E379-8937-4BE8-A1EF-6E45C5AB695BQ35960079-D0F258CB-89C1-41A2-BF47-7DB8791FD943Q35970493-DD5AB13E-6D5C-4C9A-9434-FDD2FD1E6C1FQ36060158-BD626DAD-33BD-4459-974C-300E6790F03AQ36113238-725247B4-5361-41D7-B320-CDDECDA030C2Q36140810-CD337395-B78A-470C-90C4-F30ED9F6DB05Q36340092-B7DD3F25-EF5F-40C3-807A-FB4D20A88F7BQ36368902-63EFED67-7465-43B2-9B5D-F104C6ED115AQ36429511-891CC24E-C90B-4DAF-A5C1-5432E43F80F6Q36557474-CF7EA287-5082-4BAC-AF51-AD1C1205DC37
P2860
Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer.
@en
type
label
Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer.
@en
prefLabel
Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer.
@en
P2093
P2860
P1433
P1476
Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer.
@en
P2093
Howard-McNatt M
Vona-Davis L
P2860
P304
P356
10.1111/J.1467-789X.2007.00396.X
P577
2007-09-01T00:00:00Z